Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy

Luteolin as an adjuvant effectively enhanced the efficacy of adoptive tumor-specific CTLs therapy

Abstract Background Luteolin, a natural flavonoid compound, has demonstrated anti-inflammatory, antioxidant, and broad anti-tumor properties. Recent studies suggest that its anti-tumor effects are linked to enhanced CTL function—including proliferation, survival, and cytotoxicity-via inhibition of t...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhiheng Lai, Yanyang Pang, Yujing Zhou, Leiyuan Chen, Kai Zheng, Shiguo Yuan, Wu Wang
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Cancer
Online Access:https://doi.org/10.1186/s12885-025-13831-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items